These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 26563374)
21. NK cell recognition and killing of melanoma cells is controlled by multiple activating receptor-ligand interactions. Morgado S; Sanchez-Correa B; Casado JG; Duran E; Gayoso I; Labella F; Solana R; Tarazona R J Innate Immun; 2011; 3(4):365-73. PubMed ID: 21576932 [TBL] [Abstract][Full Text] [Related]
22. Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer. Han B; Mao FY; Zhao YL; Lv YP; Teng YS; Duan M; Chen W; Cheng P; Wang TT; Liang ZY; Zhang JY; Liu YG; Guo G; Zou QM; Zhuang Y; Peng LS J Immunol Res; 2018; 2018():6248590. PubMed ID: 30255106 [TBL] [Abstract][Full Text] [Related]
23. Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: influence of host immune and tumor markers. Wu L; Parton A; Lu L; Adams M; Schafer P; Bartlett JB Cancer Immunol Immunother; 2011 Jan; 60(1):61-73. PubMed ID: 20848094 [TBL] [Abstract][Full Text] [Related]
24. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways. Verhoeven DH; de Hooge AS; Mooiman EC; Santos SJ; ten Dam MM; Gelderblom H; Melief CJ; Hogendoorn PC; Egeler RM; van Tol MJ; Schilham MW; Lankester AC Mol Immunol; 2008 Sep; 45(15):3917-25. PubMed ID: 18657862 [TBL] [Abstract][Full Text] [Related]
25. TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA. Hu Y; Li D; Wu A; Qiu X; Di W; Huang L; Qiu L Cancer Lett; 2017 May; 393():60-67. PubMed ID: 28216373 [TBL] [Abstract][Full Text] [Related]
26. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells. Meazza R; Tuberosa C; Cetica V; Falco M; Loiacono F; Parolini S; Micalizzi C; Moretta A; Mingari MC; Moretta L; Bottino C; Aricò M; Pende D Eur J Immunol; 2014 May; 44(5):1526-34. PubMed ID: 24496997 [TBL] [Abstract][Full Text] [Related]
27. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645 [TBL] [Abstract][Full Text] [Related]
28. Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells. Okita R; Wolf D; Yasuda K; Maeda A; Yukawa T; Saisho S; Shimizu K; Yamaguchi Y; Oka M; Nakayama E; Lundqvist A; Kiessling R; Seliger B; Nakata M PLoS One; 2015; 10(10):e0139809. PubMed ID: 26439264 [TBL] [Abstract][Full Text] [Related]
29. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation. Fionda C; Soriani A; Malgarini G; Iannitto ML; Santoni A; Cippitelli M J Immunol; 2009 Oct; 183(7):4385-94. PubMed ID: 19748980 [TBL] [Abstract][Full Text] [Related]
30. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma. Zhang Z; Su T; He L; Wang H; Ji G; Liu X; Zhang Y; Dong G Tohoku J Exp Med; 2012 Jan; 226(1):59-68. PubMed ID: 22189020 [TBL] [Abstract][Full Text] [Related]
31. Cancer immunotherapy using NKG2D and DNAM-1 systems. Morisaki T; Onishi H; Katano M Anticancer Res; 2012 Jun; 32(6):2241-7. PubMed ID: 22641658 [TBL] [Abstract][Full Text] [Related]
33. NKG2D engagement on human NK cells leads to DNAM-1 hypo-responsiveness through different converging mechanisms. Milito ND; Zingoni A; Stabile H; Soriani A; Capuano C; Cippitelli M; Gismondi A; Santoni A; Paolini R; Molfetta R Eur J Immunol; 2023 Feb; 53(2):e2250198. PubMed ID: 36440686 [TBL] [Abstract][Full Text] [Related]
34. Ethanol-dependent expression of the NKG2D ligands MICA/B in human cell lines and leukocytes. Streltsova MA; Klinkova AV; Kuchukova AA; Kadin AY; Kanevskiy LM; Kovalenko EI Biochem Cell Biol; 2017 Apr; 95(2):280-288. PubMed ID: 28177768 [TBL] [Abstract][Full Text] [Related]
35. Four novel ULBP splice variants are ligands for human NKG2D. Cao W; Xi X; Wang Z; Dong L; Hao Z; Cui L; Ma C; He W Int Immunol; 2008 Aug; 20(8):981-91. PubMed ID: 18544572 [TBL] [Abstract][Full Text] [Related]
36. NKG2D ligands expression and NKG2D-mediated NK activity in Sezary patients. Dulphy N; Berrou J; Campillo JA; Bagot M; Bensussan A; Toubert A J Invest Dermatol; 2009 Feb; 129(2):359-64. PubMed ID: 18754036 [TBL] [Abstract][Full Text] [Related]
37. DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction. Ardolino M; Zingoni A; Cerboni C; Cecere F; Soriani A; Iannitto ML; Santoni A Blood; 2011 May; 117(18):4778-86. PubMed ID: 21406724 [TBL] [Abstract][Full Text] [Related]
38. Enhanced Th1 and inflammatory mRNA responses upregulate NK cell cytotoxicity and NKG2D ligand expression in human pre-eclamptic placenta and target it for NK cell attack. Vinnars MT; Björk E; Nagaev I; Ottander U; Bremme K; Holmlund U; Sverremark-Ekström E; Mincheva-Nilsson L Am J Reprod Immunol; 2018 Jul; 80(1):e12969. PubMed ID: 29741244 [TBL] [Abstract][Full Text] [Related]
39. Chimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibition. Song DG; Ye Q; Santoro S; Fang C; Best A; Powell DJ Hum Gene Ther; 2013 Mar; 24(3):295-305. PubMed ID: 23297870 [TBL] [Abstract][Full Text] [Related]
40. The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands. Elsner L; Muppala V; Gehrmann M; Lozano J; Malzahn D; Bickeböller H; Brunner E; Zientkowska M; Herrmann T; Walter L; Alves F; Multhoff G; Dressel R J Immunol; 2007 Oct; 179(8):5523-33. PubMed ID: 17911639 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]